Fusion event
HBV-chr11 integration
Detection method
PCR and Sanger sequencing
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Perfect
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
60274903/60507430 (Hg38)
Nearest miRNA
hsa-mir-129-2/Upstream/298274; hsa-let-7a-2/Downstream/1001166;
Downstream sequence
GAGCCTTTTTCAGTATGTTTAAAAAATTAATTTTGATTTGATATTGGTTGTAGAGCAGTAGA
Target sequence
TCTTTCATCTACTGGACAGAGTTCGAGAGTCCTCT
Junction sequence
GTCTGTGCCTTCTCATCTGCCGGACCGTGTGCACTTCGCTTCACCTCTGCACGTCGCATGGAAACCACCGTGAACGCCCACAGGAACCTGCCCAAGGTCTTGCATAAGAGGACTCTTGGACTTTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTGTGTTTACTGAGCCTTTTTCAGTATGTTTAAAAAATTAATTTTGATTTGATATTGGTTGTAGAGCAGTAGA
* Color:
Human Sequence
/
Virus Sequence
/
Overlapped sequence
/
Unknown sequence
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.